Skip over global navigation links
U.S. Department of Health and Human Services

2010 PHEMCE Review

Emerging infectious diseases, pandemics, and bioterrorism carry the potential for catastrophic impact, and the U.S. government has faced chronic challenges in producing medical countermeasures against such threats, as exemplified during the recent 2009-H1N1 pandemic. The President called out the renewed need for a national capability to respond to these threats in the State of the Union, and the Secretary of HHS stepped forward to address this need. The vision to combat such threats is simple: our nation must have the nimble, flexible capability to produce medical countermeasures rapidly in the face of any attack or threat, whether known or unknown, novel or reemerging, natural or intentional.

The business model of the current medical countermeasure development enterprise requires new, innovative approaches to meet this vision. The new strategy envisions a capabilities-based approach and a much more active role by the U.S. government in forging partnerships, attacking constraints, modernizing regulatory oversight, and supporting transformative technologies. It also addresses federal leadership and management practices needed to produce an integrated and successful program.

  • This page last reviewed: August 10, 2017